Chinese lifesciences firm HitGen raises $38.9m Series B led by CDH, Leadyond

Chinese lifesciences firm HitGen raises $38.9m Series B led by CDH, Leadyond

Photo: Pixabay

Juliet Shwe Gaung

29 May, 2018

CDH Investments.HitGenLeadyond capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.